CA2711292A1 - Inhalation drug products, systems and uses - Google Patents

Inhalation drug products, systems and uses Download PDF

Info

Publication number
CA2711292A1
CA2711292A1 CA2711292A CA2711292A CA2711292A1 CA 2711292 A1 CA2711292 A1 CA 2711292A1 CA 2711292 A CA2711292 A CA 2711292A CA 2711292 A CA2711292 A CA 2711292A CA 2711292 A1 CA2711292 A1 CA 2711292A1
Authority
CA
Canada
Prior art keywords
drug product
chamber
fine particle
formulation
particle fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2711292A
Other languages
English (en)
French (fr)
Inventor
Ying Li
Jill K. Sherwood
Barbara Haeberlin
Ian Laurence Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Merck Sharp and Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2711292A1 publication Critical patent/CA2711292A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2711292A 2008-01-10 2009-01-09 Inhalation drug products, systems and uses Abandoned CA2711292A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2033308P 2008-01-10 2008-01-10
US61/020,333 2008-01-10
PCT/US2009/030562 WO2009089422A2 (en) 2008-01-10 2009-01-09 Inhalation drug products, systems and uses

Publications (1)

Publication Number Publication Date
CA2711292A1 true CA2711292A1 (en) 2009-07-16

Family

ID=40514046

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2711292A Abandoned CA2711292A1 (en) 2008-01-10 2009-01-09 Inhalation drug products, systems and uses

Country Status (6)

Country Link
US (1) US20110182830A1 (OSRAM)
EP (1) EP2244692A2 (OSRAM)
JP (1) JP2011509936A (OSRAM)
CA (1) CA2711292A1 (OSRAM)
MX (1) MX2010007569A (OSRAM)
WO (1) WO2009089422A2 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
CN115813935A (zh) * 2021-09-16 2023-03-21 上海上药信谊药厂有限公司 药物组合物、气雾剂及其制备方法和气雾剂产生系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
US20080210225A1 (en) * 2007-03-01 2008-09-04 Rapha Institute For Health Disposable antistatic spacer

Also Published As

Publication number Publication date
JP2011509936A (ja) 2011-03-31
EP2244692A2 (en) 2010-11-03
WO2009089422A2 (en) 2009-07-16
US20110182830A1 (en) 2011-07-28
MX2010007569A (es) 2011-03-21
WO2009089422A3 (en) 2010-09-10

Similar Documents

Publication Publication Date Title
JP5170789B2 (ja) 喘息治療用の製薬組成物
AU2002313828A1 (en) Pharmaceutical compositions for the treatment of asthma
AU2008217586A1 (en) Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
TW202114642A (zh) 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US20100095963A1 (en) Pharmaceutical compositions
JP3264496B2 (ja) クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物
CN101652123A (zh) 稳定的药物气雾剂
CA2711292A1 (en) Inhalation drug products, systems and uses
WO2021146176A1 (en) Medicinal compositions for carbon dioxide based metered dose inhalers
EP1785156B1 (en) Metered dose inhaler containing an aerosol suspension formulation
HK1128428B (en) Pharmaceutical compositions for the treatment of asthma
HK1151987B (en) Pharmaceutical compositions for the treatment of asthma
HK1060972B (en) Pharmaceutical compositions for the treatment of asthma

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140108

FZDE Discontinued

Effective date: 20160930